Tibet AIM Pharm. Company Description
Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company’s products include Miglitol tablets for diabetes; ethnic medicine products, suitable for treating breast lobular hyperplasia, uterine fibroids, and ovarian cysts; medicines for gynecology and obstetrics; and Gualoupi injection, Nalmefene hydrochloride injection, and Carbetocin injection.
It also provides Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; and Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems.
Tibet AIM Pharm. Inc. was founded in 2003 and is based in Lhasa, China.
| Country | China |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 405 |
| CEO | Ke Xu |
Contact Details
Address: No. 6, Linqionggang Road Lhasa, 850000 China | |
| Phone | 86 10 5873 1208 |
| Website | emyy.cn |
Stock Details
| Ticker Symbol | 002826 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002C39 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ke Xu | GM and Chief Financial Officer |
| Qianjin Li | Secretary of the Board of Directors |